We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+10.58%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.8B
AUM Growth
+$221M
Cap. Flow
+$80.9M
Cap. Flow %
4.48%
Top 10 Hldgs %
44.39%
Holding
281
New
54
Increased
86
Reduced
86
Closed
9

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$12.5M
2
VZ icon
Verizon
VZ
+$7.16M
3
CCI icon
Crown Castle
CCI
+$6.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.91M
5
CTSH icon
Cognizant
CTSH
+$5.75M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.91%
2 Technology 18.28%
3 Healthcare 13.65%
4 Financials 11.05%
5 Consumer Discretionary 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMT icon
1
Walmart Inc
WMT
$868B
$226M 12.51%
4,775,229
-50,721
-1% -$2.41M
SPY icon
2
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$113M 6.23%
294,204
+250,379
+571% +$96.2M
KO icon
3
Coca-Cola
KO
$355B
$103M 5.69%
1,614,421
+328,735
+26% +$19.8M
AAPL icon
4
Apple
AAPL
$4.76T
$85.5M 4.74%
657,677
-6,319
-1% -$903K
MSFT icon
5
Microsoft
MSFT
$2.89T
$56.9M 3.15%
237,342
+2,945
+1% +$707K
AMGN icon
6
Amgen
AMGN
$197B
$53.3M 2.95%
202,764
-517
-0.3% -$139K
PG icon
7
Procter & Gamble
PG
$347B
$45.3M 2.51%
299,151
-176
-0.1% -$24.7K
SPGI icon
8
S&P Global
SPGI
$127B
$43.8M 2.43%
130,759
+2,659
+2% +$876K
CVX icon
9
Chevron
CVX
$384B
$40.5M 2.24%
225,401
+7,139
+3% +$1.25M
JNJ icon
10
Johnson & Johnson
JNJ
$613B
$35M 1.94%
198,353
+5,023
+3% +$867K
MCD icon
11
McDonald's
MCD
$186B
$24.9M 1.38%
94,501
+4,406
+5% +$1.16M
XOM icon
12
ExxonMobil
XOM
$640B
$24.3M 1.35%
220,717
+24,554
+13% +$2.63M
JPM icon
13
JPMorgan Chase
JPM
$924B
$23.3M 1.29%
173,417
-21,358
-11% -$2.71M
ABBV icon
14
AbbVie
ABBV
$446B
$20.3M 1.12%
125,524
+3,947
+3% +$605K
LOW icon
15
Lowe's Companies
LOW
$114B
$19.7M 1.09%
98,992
-718
-0.7% -$144K
AFL icon
16
Aflac
AFL
$62.6B
$18.9M 1.05%
262,908
+10,747
+4% +$720K
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$120B
$18.7M 1.04%
64,881
-19,400
-23% -$5.91M
EA icon
18
Electronic Arts
EA
$52.4B
$18.7M 1.04%
153,261
-17,784
-10% -$2.23M
PAYX icon
19
Paychex
PAYX
$39.3B
$18.1M 1%
156,880
-3,053
-2% -$357K
TJX icon
20
TJX Companies
TJX
$171B
$17.8M 0.98%
223,148
-1,998
-0.9% -$148K
CVS icon
21
CVS Health
CVS
$138B
$17.7M 0.98%
190,117
+2,569
+1% +$248K
ORCL icon
22
Oracle
ORCL
$364B
$17.6M 0.98%
215,319
-7,735
-3% -$588K
TXN icon
23
Texas Instruments
TXN
$268B
$16.8M 0.93%
101,981
-12,240
-11% -$2.04M
CSCO icon
24
Cisco
CSCO
$443B
$16.5M 0.92%
346,954
-56,464
-14% -$2.57M
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$4.21T
$15.9M 0.88%
180,400
-9,240
-5% -$878K

Similar funds

Cullinan Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Cullinan Associates held 281 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cullinan Associates deployed $80.9M of net new capital in Q4 2022, opening 54 new positions and adding to 86 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 11,200 shares worth $3.94M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Verizon, an estimated $7.16M trimmed.

  • Cullinan Associates's largest Q4 2022 buy was Vanguard S&P 500 ETF: 11,200 shares worth $3.94M.
  • Cullinan Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $96.2M increase.
  • Cullinan Associates's biggest Q4 2022 reduction was Verizon, cutting an estimated $7.16M.
  • Cullinan Associates fully exited Public Storage in Q4 2022, selling an estimated $12.5M.
  • Cullinan Associates's ten largest holdings make up 44% of its $1.8B portfolio in Q4 2022.
  • Cullinan Associates opened 54 new positions and closed 9 in Q4 2022.
  • Cullinan Associates's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Cullinan Associates's 13F filing for Q4 2022, filed 11 Jan 2023.